EDITORIAL
Accepted on 21 Oct 2025
Editorial: Checkpoint Immunotherapy - Reshaping the Landscape of Gastrointestinal Cancer Treatment
doi 10.3389/fimmu.2025.1723645
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Checkpoint Immunotherapy: Reshaping the Landscape of Gastrointestinal Cancer Treatment
Checkpoint Immunotherapy: Reshaping the Landscape of Gastrointestinal Cancer Treatment
11k
Total downloads
52k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 14 Oct 2025
Cost-effectiveness of cadonilimab plus chemotherapy vs chemotherapy alone for advanced gastric cancer: evidence to inform drug pricing in the U.S. and China
doi 10.3389/fimmu.2025.1618726
- 336 views
ORIGINAL RESEARCH
Published on 01 Sep 2025
Liquid-liquid phase separation in gastric cancer: identifying novel biomarkers and therapeutic targets through gene signature analysis
doi 10.3389/fimmu.2025.1620390
- 1,684 views
ORIGINAL RESEARCH
Published on 27 Aug 2025
Efficacy and safety of postoperative adjuvant HAIC combining lenvatinib with or without PD-1 inhibitors in solitary large HCC: A multicenter retrospective study
doi 10.3389/fimmu.2025.1609352
- 1,198 views
ORIGINAL RESEARCH
Published on 18 Jul 2025
Additions of trastuzumab to preoperative chemotherapy or chemoimmunotherapy for patients with potentially resectable stage III to IVB HER2-positive gastric cancer
doi 10.3389/fimmu.2025.1624943
- 1,470 views
CASE REPORT
Published on 18 Jul 2025
Case Report: Pathological complete response achieved with neoadjuvant immunochemotherapy in synchronous multiple gastric adenocarcinoma
doi 10.3389/fimmu.2025.1611281
- 1,109 views
CASE REPORT
Published on 27 Jun 2025
Hyperbaric oxygen therapy as an immunosensitizing strategy in advanced gastric hepatoid adenocarcinoma: a case report
doi 10.3389/fimmu.2025.1625273
- 1,578 views
ORIGINAL RESEARCH
Published on 13 May 2025
Cost-effectiveness analysis of first-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma
doi 10.3389/fimmu.2025.1575627
- 2,095 views
- 3 citations
ORIGINAL RESEARCH
Published on 25 Apr 2025
In vivo RNAi screen and validation reveals Ngp, Hba-a1, and S100a8 as novel inhibitory targets on T lymphocytes in liver cancer
doi 10.3389/fimmu.2025.1549229
- 2,350 views
ORIGINAL RESEARCH
Published on 31 Mar 2025
Efficacy and safety of immune checkpoint inhibitors in advanced biliary tract cancer: a real-world study
doi 10.3389/fimmu.2025.1493234
- 2,263 views
- 2 citations
STUDY PROTOCOL
Published on 25 Feb 2025
Nab-paclitaxel combined with cadonilimab (AK104) as second-line treatment for advanced gastric cancer: protocol for a phase II prospective, multicenter, single-arm clinical trial
doi 10.3389/fimmu.2025.1519545
- 3,632 views
- 1 citation
SYSTEMATIC REVIEW
Published on 27 Jan 2025
Neoadjuvant immunotherapy for DNA mismatch repair proficient/microsatellite stable non-metastatic rectal cancer: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1523455
- 4,710 views
- 3 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore